Intelligent Bio Solutions Inc. (NASDAQ: INBS) completed penetration testing for its upcoming FDA 510(k) submission, with no major vulnerabilities identified ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA